← Open Payments lookup

SACHIN MEHTA: Open Payments

NPI 1295926194 · BLUE BELL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$306,740 in 379 payments from 16 companies in 2025. Trend: 2023 $114,581 · 2024 $178,492 · 2025 $306,740

Speaker / faculty: $214,642Honoraria: $42,763Travel & lodging: $27,152Consulting: $11,966Food & beverage: $10,217
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.82$92,633
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)95$73,566
Axsome Therapeutics, Inc.49$47,859
Teva Pharmaceuticals USA, Inc.38$37,400
ABBVIE INC.46$28,729
Alkermes, Inc.42$25,953
Otsuka America Pharmaceutical, Inc.5$118
Vanda Pharmaceuticals Inc.4$89
Collegium Pharmaceutical, Inc.4$86
Supernus Pharmaceuticals, Inc.4$80

Products named: COBENFY, CAPLYTA, Auvelity, UZEDY, VRAYLAR, LYBALVI, REXULTI, ARISTADA.

Industry payments across PA — which companies pay providers there.